Breaking News

PPD Appoints Corporate Development SVP

April 22, 2014

De Silva brings 15 years of biopharma experience

Bhooshi De Silva has been appointed senior vice president of corporate development and strategy at PPD, and joins the executive leadership team. Mr. De Silva will focus on key strategic initiatives to support growth, including corporate development, strategy and mergers and acquisitions.
 
Mr. De Silva has 15 years of experience in the biopharma industry and has served in leadership roles. He began his career at Pfizer, serving in roles across the R&D and commercial organizations in portfolio management, strategy and operations. His responsibilities included overseeing the development and strengthening of analytical frameworks and decision-making processes. Most recently, he served as head of business development, corporate strategy and international teams at Optimer Pharmaceuticals.
 
“Bhooshi’s vision and expertise will be invaluable in our efforts to grow our business and successfully meet the evolving needs of our clients,” said David Simmons, PPD’s chairman and chief executive officer. “He comes to PPD well-prepared to help us navigate the challenges of the changing biopharmaceutical landscape, while developing and executing a strategy for our company’s continued success.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important